Sandrine U. Crane

Sandrine U. Crane

Oncology | Hematology

1710 Kernersville Medical Parkway
Kernersville, NC 27403

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2 publications

Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.

Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.

Journal: Journal of geriatric oncology

Published: February 23, 2018

Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.

Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.

Journal: The Lancet. Oncology

Published: January 18, 2017

Showing 1-2 of 2

Last Updated: 09/26/2026